人类免疫球蛋白静脉注射剂是一种免疫治疗产品的商标名称，这种药物已经被用来治疗多种免疫系统失调疾病。
Kiovig, or Gammagard as it is known in the US, is the brand name of an immunotherapy product already used for the treatment of a variety of immune disorders.
我们的产品给予静脉注射免疫球蛋白被视为是其中一个最好的，在一个拉丁美洲的产品。
Our product IVIG is regarded as one of the best in a Latin American Products.
目的探讨静脉注射大剂量免疫球蛋白在肾移植后肺部感染治疗中的辅助作用。
Objective To evaluate the adjunctive therapeutic effect of intravenous immunoglobulin (IVIG) therapy in the pulmonary infection after kidney transplantation.
目的：探讨静脉注射用免疫球蛋白(IVIG)对儿童难治性肾病综合征(RNS)的临床疗效。
Objective: to investigate the clinical therapeutic effectiveness of intravenous immunoglobulin (IVIG) in the treatment of refractory nephritic syndrome (RNS) in children.
目的研究静脉注射大剂量免疫球蛋白(HIVIG)治疗新生儿低氧缺血性脑病(HIE)的临床疗效和免疫学机制。
ObjectiveTo study the clinical effects and possible immunological mechanism of high-dose intravenous immunoglobulin (HIVIG) in neonates with hypoxic-ischemic encephalopathy (HIE).
静脉注射免疫球蛋白作为一种免疫调节剂可治疗多种免疫相关性疾病。
Intravenous immunoglobulin has been shown to be effective in the treatment of many immune-mediated diseases as an immunomodulatory agent.
在一个比较糖皮质类固醇和静脉注射免疫球蛋白﹝33位病人﹞的试验，在14天的治疗期间没有发现任何疗法间的差异。
In a trial of glucocorticosteroids versus intravenous immunoglobulin (33 participants) no differences in treatment responses were encountered during a treatment period of 14 days.
介绍吉兰·巴雷综合征(GBS)病因治疗的循证医学证据，主要包括血浆置换、静脉注射免疫球蛋白、糖皮质激素。
To introduce etiologic therapy in evidence-based medicine (EBM) practice for Guillain-Barr syndrome (GBS), mainly including plasma exchange, intravenous immunoglobulin and glucocorticoid.
现在，国立老年研究所正尝试一种已被广泛用于免疫失调疾病的抗体疗法，即静脉注射免疫球蛋白。
Now, the National Institute on Aging is sponsoring a new trial of an antibody-based therapy already used to treat immune disorders: intravenous injection of immunoglobulins.
静脉注射免疫球蛋白自二十世纪70年代末开始用于临床，随着对其作用机理认识的逐渐深入，其临床适应症扩大。
Intravenous immunoglobulin (IVIg) has been used in clinical therapy since the end of 1970's. The clinical indications have been extended with the mechanism of IVIg known gradually.
静脉注射免疫球蛋白自二十世纪70年代末开始用于临床，随着对其作用机理认识的逐渐深入，其临床适应症扩大。
Intravenous immunoglobulin (IVIg) has been used in clinical therapy since the end of 1970's. The clinical indications have been extended with the mechanism of IVIg known gradually.
应用推荐